Researchers DanaFarber and collaborators uncover developmental enhancer signatures in pancreatic neuroendocrine tumors PNET are clinicallyrelevant markers patient stratification httpsrdcu.bebIgEk pancreaticcancer epigenetics cancerpic.twitt

Researchers @DanaFarber and collaborators uncover developmental enhancer signatures in pancreatic neuroendocrine tumors (#PNET) are clinically-relevant markers patient stratification https://rdcu.be/bIgEk  #pancreaticcancer #epigenetics #cancerpic.twitt

12:27 EDT 1 Jul 2019 | Nature Publishing

Researchers @DanaFarber and collaborators uncover developmental enhancer signatures in pancreatic neuroendocrine tumors ( #PNET) are clinically-relevant markers patient stratification https://rdcu.be/bIgEk  #pancreaticcancer #epigenetics #cancer pic.twitter.com/N9551kYE7m

More From BioPortfolio on "Researchers @DanaFarber and collaborators uncover developmental enhancer signatures in pancreatic neuroendocrine tumors (#PNET) are clinically-relevant markers patient stratification https://rdcu.be/bIgEk  #pancreaticcancer #epigenetics #cancerpic.twitt"